Biotechnology News GLIMEPIRIDE Search

BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login

Search Results

Documents 1-10 out of 10 found

Current Search: glimepiride: 10

A New Analysis Released at ADA: Lower Risk of Symptomatic Hypoglycemia with JANUVIA(TM) (sitagliptin) Compared
A new analysis presented at the American Diabetes Association (ADA) 68th Annual Scientific Sessions showed treatment with JANUVIA(TM) (sitagliptin), Merck & Co., Inc.'s diabetes medicine, was associated with a 93 percent lower risk...

Genetic Engineering News: Jun 10 2008 3:51AM
Matching: glimepiride

Find similar documents

Liraglutide Provides Multiple Benefits Over Glimepiride in Type 2 Diabetes: Presented at ADA
-- Monotherapy with liraglutide, a once-daily human glucagon-like peptide 1 (GLP-1) analogue, significantly improves glucose control in patients with type 2 diabetes compared with the oral antidiabetic drug glimepiride, researchers announced...

Doctors Guide: Jun 10 2008 12:51AM
Matching: glimepiride

Find similar documents

/ CORRECTION - Novo Nordisk
In the news release, 'Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients With Type 2 Diabetes,' issued Monday, June 9, 2008, by Novo Nordisk, we are advised by the company that in the table for the...

Macro World Investor: Jun 10 2008 2:31PM
Matching: glimepiride

Find similar documents

Calibre Macro World: Jun 10 2008 2:13PM
Matching: glimepiride

Find similar documents

Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients With Type 2 Diabe
SAN FRANCISCO, CA -- (MARKET WIRE) -- 06/09/08 -- Data presented today at the 68th Scientific Sessions of the American Diabetes Association (ADA) demonstrated that once-daily liraglutide when taken alone produced statistically significant...

Houston Chronicle: Jun 9 2008 12:24PM
Matching: glimepiride

Find similar documents

Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients With Type 2 Diabe
Data presented today at the 68th Scientific Sessions of the American Diabetes Association (ADA) demonstrated that once-daily liraglutide when taken alone produced statistically significant improvement in blood sugar (glucose) control in...

Calibre Macro World: Jun 9 2008 12:10PM
Matching: glimepiride

Find similar documents

Liraglutide Plus Metformin More Effective Than Metformin Alone for Glycaemic Control in Type 2 Diabetics: Pres
my personal edition> diabetes > news E-Mail this DGDispatch to a colleague DGDispatch SAN FRANCISCO -- June 8, 2008 -- Liraglutide plus metformin significantly improves glycaemic control compared with metformin monotherapy in...

Doctors Guide: Jun 9 2008 12:06AM
Matching: glimepiride

Find similar documents

New Data Released at Major Diabetes Meeting on Initial Combination Therapy with JANUVIA(TM) (sitagliptin), Mer
New data presented at the American Diabetes Association (ADA) 68th Annual Scientific Sessions showed initial combination therapy with JANUVIA(TM) (sitagliptin), a diabetes medicine from Merck & Co., Inc., and metformin substantially...

Genetic Engineering News: Jun 8 2008 9:48PM
Matching: glimepiride

Find similar documents

Genetic Engineering News: Jun 8 2008 9:38AM
Matching: glimepiride

Find similar documents

New Data Released at Major Diabetes Meeting on Initial Combination Therapy with JANUVIA(TM) (sitagliptin), Mer
SAN FRANCISCO-- (BUSINESS WIRE) -- New data presented at the American Diabetes Association (ADA) 68th Annual Scientific Sessions showed initial combination therapy with JANUVIA (sitagliptin), a diabetes medicine from Merck & Co., Inc...

SmartBrief: Jun 8 2008 12:38AM
Matching: glimepiride

Find similar documents

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright � 1997-2008 - BioPortfolio Limited.